Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/65085
Title: In vitro study of liver tumor induced endothelial cell angiogenesis in microfluidic platform
Authors: Xie, Yufei
Keywords: DRNTU::Engineering::Bioengineering
Issue Date: 2015
Abstract: Cancer cells metastasis is an important medical problem which causes 90% of human cancer deaths. Angiogenesis plays essential roles in metastasis and secondary tumor growth. Extensive study on tumor angiogenesis is required to understand the mechanism of tumor angiogenesis and to find out efficient anti-angiogenic therapy. Microfluidic system, mimicking the real metastatic physiological situations, is increasingly being utilized to study tumor angiogenesis. In this study, a new 3D microfluidic model was designed and applied to study the effect of liver tumor-induced endothelial angiogenesis. Human umbilical vein endothelial cells (HUVEC-C3) transfected with the caspase-3-based FRET biosensor that are capable of indicating caspase-3 activation were seeded into microchannels, and results indicated that the addition of liver hepatocellular carcinoma (Hep-G2) cell can promote the angiogenesis of HUVEC-C3 cells towards the Hep-G2 cell spheroids. Subsequently, the successfully designed 3D micro-fluidic systems will be utilized to study the effect of angiogenesis inducing factors vessel-endothelial growth factor (VEGF) and tumor growth factor-beta (TGF-beta), anti-cancer drug (Taxol and angiogenesis inhibitor as well.
URI: http://hdl.handle.net/10356/65085
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SCBE Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
SCBE FYP Report _ Yufei XIE _ U1122757D (2).pdf
  Restricted Access
945.96 kBAdobe PDFView/Open

Page view(s)

113
Updated on Nov 30, 2020

Download(s)

13
Updated on Nov 30, 2020

Google ScholarTM

Check

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.